Arq. Bras. Cardiol. 2023; 120(7): e20220501

Misdiagnosis of a Cardiac Angiosarcoma During the COVID-19 Pandemic

Arash Amin, Zohreh Taheri, Mahshid Hesami, Azin Alizahehasl, Zeinab Norouzi ORCID logo , Nasibeh Mohammadi

DOI: 10.36660/abc.20220501

Abstract

The final months of 2019 saw the emergence of a new pandemic termed “COVID-19”. Since then, this infection and its complications have been the priority of healthcare providers, with many symptoms attributed to its early and late presentations. Thus far, other diseases, even fatal situations, have been overlooked or misdiagnosed due to the attribution of patient symptoms to the presence of COVID-19 infection. We herein present a case of cardiac angiosarcoma in a young boy who had previously become infected with COVID-19 about two months earlier. Given the history of infection, the initial approach was post-COVID-19 myopericarditis management. However, the patient’s condition worsened, necessitating reevaluation via multimodalities with higher precision. Ultimately, the patient was diagnosed with a cardiac tumor. This article seeks to underscore the significance of taking heed of other diseases and fatal conditions during the COVID-19 pandemic with an emphasis on avoiding misdiagnosing other diseases.

Misdiagnosis of a Cardiac Angiosarcoma During the COVID-19 Pandemic

Comments

Skip to content